We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
GoPower offers comprehensive portable solar energy solutions, designed to save you money and reduce your environmental impact. Their user-friendly solar panels eliminate the need for complex installations, allowing easy setup anywhere. Their portable solar power stations, providing up to 1000w/1280WH at 240v, are perfect for various applications such as home offices, garden rooms, boats, events, and more. With multiple output sockets and versatile charging options including solar panels and mains electricity, GoPower provides a greener and cost-effective energy alternative.
days to go: Extended investment: £10,000
Rype addresses the dilemma of choosing between expensive or low-quality office furniture that contributes to carbon emissions and waste. By remanufacturing high-quality used office furniture, Rype offers cost-effective solutions with 80% lower carbon emissions and waste, while creating local jobs. Their mission is to significantly reduce office carbon emissions and costs through sustainable, circular economy practices, including exclusive furniture ranges made from waste materials. Rype's comprehensive services encompass furniture sourcing, remanufacturing, and employing marginalized individuals, contributing to a more environmentally friendly and socially responsible approach to office furnishings.
days to go: Extended investment: Withheld
Arcis Biotechnology provide nucleic acid sample preparation solutions. They have made the process of obtaining genetic material from biological samples less time consuming so it can be done in less than 3 minutes.
days to go: Expired investment: £1,146,318
Metrion Biosciences is a pharmaceutical research organisation that provide a high quality drug discovery services for ion channel targets to clients on a fee-for-service or collaboration basis.
days to go: Expired investment: £465,150
Plantwork Systems (PWS) is an eco-conscious, technology company providing sustainable and environmentally friendly solutions to the wastewater treatment industry. It is the developer, owner, and provider of a range of proprietary technologies such as TN-REM, NUTREM®, and the deHoxar Spiral Separator. These products aid in nutrient removal, improved filtration, sludge thickening. This leads to wastewater treatment plants recycling more water, reducing their energy requirements, and minimising water scarcity. The company has generated combined revenues of £1.44 million since July 2017. PWS is seeking funding of up to £1 million, at a pre-money valuation of £6 million. It will use the investment to accelerate its growth and bring more innovative products to the market. 

Pitch Rated

67%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £244,865
Elemental is an agricultural food technology company that converts 78% of beef processing waste into sustainable fertiliser. The company claims that its technology can potentially reduce global beef CO2 emissions equivalent to 50 million cattle. Elemental asserts that its technology has been developed through extensive R&D and protected by patents in 60+ countries. The company raised £1.5 million on Crowdcube in late 2019, signed agreements for 14 projects in the UK and Europe using its technology, built a demonstrator plant and agreed to install its technology on commercial terms at 6 UK abattoirs. The company states they will use the investment to operationalise their first plant by December 2021 and grow their business across different verticals.

Pitch Rated

70%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £1,395,801
Earth Broadband stands out as one of the UK's pioneering green broadband providers, revolutionizing the way people use broadband services for environmental good. Founded by Luke Chapman in 2022 after witnessing climate change effects in Indonesia, the company aims to reshape broadband services, offering wildlife-themed packages and facilitating monthly contributions to planet-saving initiatives. Using innovative AI technology, Earth Broadband enhances customer service while empowering users to contribute to environmental causes by planting trees and removing ocean plastic through their app. The company's strategy focuses on achieving large-scale impact with a small, efficient team, aiming to revolutionize broadband provision.
days to go: Expired investment: £308,580
Ripple is the UK's first-ever clean energy ownership platform. The company aims to enable households and businesses to own new wind farms and solar parks and have the electricity they generate supplied to their home or business premises via the grid. It endeavours to become a segment leader in the $11 trillion global wind and solar market. Ripple has overseen £1 million+ transactions on its platform to date. It has featured in publications like The Times, CNBC, Independent, Business Green, and This Is Money. It has also garnered 5300+ pre-registered customers. The company will use 40% of the investment for marketing purposes, 40% for projects and business overheads, 10% for Non-UK projects, and 10% for website and application development.

Pitch Rated

85%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £442,282
SuperCarers is an online platform that helps families to find trusted carers living in their local area. SuperCarers do not have the high overhead costs of agencies and therefore enable supercarers to be paid significantly more than the national living wage. 
days to go: Expired investment: £1,079,495
Imagen is a company that has developed an automated, sophisticated algorithmic technique, PredictRx, to find the right treatment for any cancer type. Imagen collects the cancer samples from a patient, grows it in its specialised growth medium, and then subjects the medium to an automated fluorescence microscopy screening to measure drug responses on live tumour cells. The company's AI-powered biobank of over 150,000 drug responses then gives the best possible cancer treatment options, allowing the company to expand in the pharmaceutical sector by satisfying its unmet demand for patient-derived cancer models. Imgen requires investment to scale its infrastructure to create the world's leading 'Biobank' of clinically relevant patient-derived cancer models whilst building the most comprehensive big data set available in cancer research.

Pitch Rated

79%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £1,036,436
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph